Histamine has also been implicated in the modification of the invasive phenotype in MDA-MB-231 breast cancer cells by decreasing cell adhesion and altering the balance between matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of metalloproteinase 2 (TIMP-2) [16,17]. Here, TIMP2 is linked to breast cancer.